678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations.
Saved in:
| Title: | 678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations. |
|---|---|
| Authors: | Lemech, C.1 (AUTHOR), Luke, J.J.2 (AUTHOR), Falchook, G.S.3 (AUTHOR), Mckean, M.4 (AUTHOR), Kichenadasse, G.5 (AUTHOR), Teng, C.1 (AUTHOR), Vandross, A.L.6 (AUTHOR), Salkeni, M.A.7 (AUTHOR), Atkinson, V.G.8 (AUTHOR), Liu, J.J.9 (AUTHOR), Kennedy, A.M.10 (AUTHOR), Clark, J.10 (AUTHOR), Ryan, M.11 (AUTHOR), Schmidt-Kittler, O.11 (AUTHOR), Steinhubel, D.11 (AUTHOR), Wages, D.12 (AUTHOR), Komarnitsky, P.10 (AUTHOR), Puzanov, I.13 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS528-S529. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179692141 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lemech%2C+C%2E%22">Lemech, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luke%2C+J%2EJ%2E%22">Luke, J.J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falchook%2C+G%2ES%2E%22">Falchook, G.S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mckean%2C+M%2E%22">Mckean, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kichenadasse%2C+G%2E%22">Kichenadasse, G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Teng%2C+C%2E%22">Teng, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vandross%2C+A%2EL%2E%22">Vandross, A.L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salkeni%2C+M%2EA%2E%22">Salkeni, M.A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Atkinson%2C+V%2EG%2E%22">Atkinson, V.G.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+J%2EJ%2E%22">Liu, J.J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kennedy%2C+A%2EM%2E%22">Kennedy, A.M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Clark%2C+J%2E%22">Clark, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ryan%2C+M%2E%22">Ryan, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmidt-Kittler%2C+O%2E%22">Schmidt-Kittler, O.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Steinhubel%2C+D%2E%22">Steinhubel, D.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wages%2C+D%2E%22">Wages, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Komarnitsky%2C+P%2E%22">Komarnitsky, P.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Puzanov%2C+I%2E%22">Puzanov, I.</searchLink><relatesTo>13</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS528-S529. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692141 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.744 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S528 Titles: – TitleFull: 678TiP A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lemech, C. – PersonEntity: Name: NameFull: Luke, J.J. – PersonEntity: Name: NameFull: Falchook, G.S. – PersonEntity: Name: NameFull: Mckean, M. – PersonEntity: Name: NameFull: Kichenadasse, G. – PersonEntity: Name: NameFull: Teng, C. – PersonEntity: Name: NameFull: Vandross, A.L. – PersonEntity: Name: NameFull: Salkeni, M.A. – PersonEntity: Name: NameFull: Atkinson, V.G. – PersonEntity: Name: NameFull: Liu, J.J. – PersonEntity: Name: NameFull: Kennedy, A.M. – PersonEntity: Name: NameFull: Clark, J. – PersonEntity: Name: NameFull: Ryan, M. – PersonEntity: Name: NameFull: Schmidt-Kittler, O. – PersonEntity: Name: NameFull: Steinhubel, D. – PersonEntity: Name: NameFull: Wages, D. – PersonEntity: Name: NameFull: Komarnitsky, P. – PersonEntity: Name: NameFull: Puzanov, I. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |